Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100255 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01100255 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 15 participants.
The verdict
NCT01100255, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).
Interventions
- OTHER Saline
- DRUG Ketamine infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01100255
The ClinicalTrials.gov registry entry for NCT01100255 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01100255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01100255 about?
NCT01100255 is a clinical study titled "Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)". In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).
What is the current status of trial NCT01100255?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2010-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01100255?
The interventions under investigation include: Saline (OTHER), Ketamine infusion (DRUG).
Who is sponsoring clinical trial NCT01100255?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.